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Fig.1: Results for RLNU (training). TOP: (left) feature 
calculated at each voxel dimension against patient rank. 
(right) Feature normalised by voxel number in 
ROI. BOTTOM: (left) Surface model to calculate feature 
change. (right) Surface model shifted result. 
 
 
 
Fig.2: CCC heatmap for each feature (validation dataset) 
Conclusion 
We developed, tested and validated a novel normalisation 
technique for voxel size dependent radiomic features. On-
going work aims at validating the proposed approach on 
other imaging modalities.  
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Purpose or Objective 
Radiomics aims at extracting quantitative features from 
medical images. Several studies focussed on the potential 
value of radiomic analysis in predicting tumour response 
for oesophageal cancer (OC) patients using contrast 
enhanced CT images. However, in clinical practice 
contrast agents are not always administrable, making the 
development of a new radiomic model necessary. In this 
work, we investigated the usefulness of radiomic features 
extracted from contrast and non-contrast enhanced CT 
scans in the development of a prognostic model in OC. 
Material and Methods 
CT images and radiotherapy volumes of 213 patients from 
a clinical trial in OC1were processed with the CERR 
package2. Patients were divided into 3 groups: mixed 
group (MG) with contrast and non-contrast enhanced CT 
images (n=213), contrast group (CG) with contrast 
enhanced CT scans (n=138) and non-contrast group (nCG) 
with non-contrast enhanced CT data (n=75). Radiomic 
features were automatically extracted in 2D and 3D in 
compliance with the IBSI3, using in-house developed data 
analytics software4. Stable features were selected as the 
ones with similar intra-groups distributions (Kruskal-Wallis 
test). Corresponding 2D and 3D stable features within each 
group were evaluated for differences (Wilcoxon signed 
rank test). Remaining filtered features and clinical 
characteristics were used to develop a prognostic model 
with the Cox regression method. 
Results 
A total of 119 2D and 3D features were computed from 
each group. The Kruskal-Wallis test excluded 82, 3 and 6 
unstable features obtained from MG, from CG and from 
nCG, respectively (Fig. 1). Some stable features (6 for MG, 
15 for CG and 17 for nCG) did not show a significant 
difference if extracted considering 1 tumour layer at a 
time or considering the whole tumour volume. Among 
stable features, 4 features showed no difference if 
obtained from 3D or 2D data and were stable in all the 3 
groups. The Cox regression model, constructed with 8 
clinical and radiomic variables, identified 1 feature 
(GLDZM zone distance variance) associated with survival 
(Table 1). 
 
 
 
Conclusion 
The prognostic model has identified 1 texture significantly 
and independently correlated with overall survival. This 
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feature can add value over and above currently known 
prognostic factors if computed in 2D or 3D and 
independently from administration of CT contrast agents. 
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Purpose or Objective 
One of the major issues in radiomics is the very large 
amount of tested extracted features, compared to the 
often-reduced sample size and the low number of events. 
Reduction of dimensionality may be therefore an 
important preliminary step to improve the prediction 
capability of the predictive models. The aims of the study 
were: 
- to propose methods for reducing redundancy by selecting 
the more informative features from -multimodal images; 
- to evaluate and compare the prediction capability of the 
models when using these methods. 
The considered example was MRI based radiomics to 
predict overall survival after SBRT for hepatocellular 
carcinoma (HCC). 
Material and Methods 
Eighty-one patients underwent SBRT for inoperable HCC. 
For each patient, 7 modalities of MR images were 
acquired. A total of 273 features were extracted from 
manually delineated tumours belonging to 4 radiomics 
categories (geometrical, first order, gradient-based and 
second order) in each modality. As we follow the workflow 
[Figure 1]  
 
 
 
, a similarity measure based on Spearman correlation was 
computed across the features. Four methods for feature 
selection were then assessed namely three unsupervised 
(K-means, Hierarchical clustering (HC) and Affinity 
propagation (AP)) and a supervised (mRMR) clustering and 
compared random selection (RS) and no selection (using 
all the features). Affinity propagation clustering yields a 
set of exemplars which better represented each cluster. 
Finally, in order to assess the predictive capabilities of 
each one of the feature selection method, a random forest 
classifier was trained and tested via a stratified-K-fold 
(K=19 the occurrence of decease event) cross-validation. 
This process was repeated 1000 times. Feature importance 
as assessed by aggregation of the performance at each try. 
The performance is evaluated by computing the precision 
(True positive / True positive + True negative) of 
prediction. 
Results 
The table displays the selected predictive feature 
depending on the selection methods. Unsupervised 
clustering algorithms allowed to select a non-redundant 
set of features able to significantly better predict HCC 
overall survival [Exemplars from AP: Precision= 0.76 ± 
0.01, (p-value < 0.001)], in comparison to the other 
methods [All features: Precision = 0.73 ± 0.001; RS from 
all features : Precision = 0.71 ± 0.3 ; RS from K-means 
clustering : Precision =  0.715 ± 0.1; RS from HC: Precision 
= 0.74 ± 0.02; RS from AP clustering: Precision = 0.735 ± 
0.01 and exemplars from mRMR: Precision = 0.735 ± 0.01] 
. The most reproducible predictive features are related 
with the shape of the tumour [Figure 2] 
 
. 
 
Conclusion 
A framework for feature selection in a radiomics workflow 
is presented. Unsupervised methods allow to cluster 
together groups of features increasing the prediction 
capabilities and reducing redundancy. AP outperforms the 
other features selection method suggesting the use of the 
exemplars as representative feature of each cluster.  
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